C1Q+ TPP1+ macrophages promote colon cancer progression through SETD8-driven p53 methylation

Abstract

These findings suggest that p53^K382me1 may be an early step in tumor initiation, especially in inflammation-induced CRC, and could serve as a functional biomarker and therapeutic target in adjuvant setting for advanced CRCs.